Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Total Liabilities (2016 - 2025)

Jaguar Health (JAGX) has disclosed Total Liabilities for 11 consecutive years, with $45.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 5.2% to $45.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $45.1 million, a 5.2% increase, with the full-year FY2024 number at $44.4 million, down 3.1% from a year prior.
  • Total Liabilities was $45.1 million for Q3 2025 at Jaguar Health, up from $41.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $49.3 million in Q1 2023 to a low of $36.8 million in Q1 2021.
  • A 5-year average of $43.8 million and a median of $44.4 million in 2024 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: skyrocketed 120.91% in 2021, then decreased 16.61% in 2024.
  • Jaguar Health's Total Liabilities stood at $41.4 million in 2021, then rose by 17.86% to $48.8 million in 2022, then decreased by 6.03% to $45.9 million in 2023, then fell by 3.1% to $44.4 million in 2024, then increased by 1.5% to $45.1 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Total Liabilities are $45.1 million (Q3 2025), $41.4 million (Q2 2025), and $48.1 million (Q1 2025).